王进

2017-11-03 20:36:00
新世路
原创
472
摘要:创业导师

王进    创业导师

建信润康创始人兼总经理、曼哈顿资本共同创始人.海外华人中最早(90年代中后)进入生物科技风险投资领域的专业人士. 从业VC早期投资20年,拥有学术界,产业界和金融界工作背景和良好业绩,曾经担任美国知名生物医药风险投资公司派拉蒙资本(Paramount Capital)生物医药风险投资基金亚太中国区主管,负责投资操盘中国首创的砒霜治疗白血病的项目.以虚拟公司(PolaRx Biopharma Inc).方式运行,投资三年多就获得了巨大投资回报。2002年他回国创办曼哈顿资本管理咨询公司,主要从事投资孵化早期生物医药和健康产业科技公司,投资偏重新药研发,疫苗,器械,诊断,疾病管理,大健康/大数据,精准和移动医疗领域,已累计投资,创办和孵化了二十多家中外创新企业,从事专业风险投资前.他曾在罗氏公司从事过抗癌抗病毒新药研发.在美国联合医药集团做过企业融资,并购和跨境投资.回国创业前,他曾在美国生物科技上市公司细胞治疗CTI,担任过中国区商务与临床开发负责人 

王进博士毕业于浙江大学(原杭州大学)生物系。 在美国伍斯特理工(WPI)获得生物医学博士。他是美中药协SAPA早期创始人.他是丁香园,京天成,经纬生物,优思达和四方医药等十多家公司的早期投资者或/和共同创办人,担任多家国内外生物技术公司顾问或董事,经常受邀在生物医药投资论坛发表讲演,并为专业媒体撰稿。

Dr. Jin Wang

Managing Partner Jianxin RunKang Capital and Founding Partner of Manhattan Capital Group

Angel investor & co-founder of famous Medical Social Network Company (丁香园www.dxy.cn) 

In late 90s, he joined Paramount Capital, serviced as an Asia/Great China Regional Director, he also provided value-added service as a venture partner & executive for a portfolio company, PolaRx Biopharma. After that, he became a China Head for business & clinical development of a public company, Cell Therapeutic, Inc  In 2002, he return to China, started his own VC firm, MCG Group and invested more than 20 biotech or healthcare related company in China and US. He is co-founder of SAPA, In his early research career He used to work for Worcester foundation and Roche Pharmaceutical He obtained BS from Zhejiang University and Ph.D.in Biomedicine from WPI in US.